CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net loss	$ (5,383,432)	$ (6,097,760)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	300,419	276,608
Fair value of vested options issued to officers, directors and employees	1,564,311	459,967
Amortization of capitalized financing costs	85,975	731,595
Amortization of debt discount attributable to convertible debentures	541,120	1,549,230
Fair value of vested warrants issued for service	58,238	567,083
Common stock issued in settlement of interest	507,939	34,960
Changes in operating assets and liabilities:
Increase in accounts receivable	(234,180)	(114,804)
(Increase) decrease in prepaid expenses and deposits	(44,247)	43,645
(Decrease) increase in accounts payable and accrued liabilities	(389,151)	348,822
Increase in deferred revenue	25,000
Net cash used in operating activities	(2,968,008)	(2,200,654)
Cash flows from investing activities:
Purchase of property and equipment	(65,792)
Net cash used in investing activities	(65,792)
Cash flows from financing activities:
Net proceeds from (payments of) related party advances		550,000
Net proceeds from sale of common stock	1,542,600
Net proceeds from issuance of convertible notes		1,645,500
Net cash provided by financing activities	1,542,600	2,195,500
Net increase in cash and cash equivalents	(1,491,200)	(5,154)
Cash and cash equivalents at beginning of period	2,747,294	17,618
Cash and cash equivalents at end of period	1,256,094	12,464
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for taxes
Non-cash transactions:
Fair value of warrants issued for financing costs		217,971
Common stock issued in exchange for previously incurred debt	$ 4,022,000	$ 389,960